APA (7th ed.) Citation

Hazemann, J., Kimmerlin, T., Mac Sweeney, A., Bourquin, G., Lange, R., Ritz, D., . . . Czodrowski, P. (2025). Accelerating the Hit-To-Lead Optimization of a SARS-CoV-2 Mpro Inhibitor Series by Combining High-Throughput Medicinal Chemistry and Computational Simulations. Journal of medicinal chemistry, 68(8), 8269-8294. https://doi.org/10.1021/acs.jmedchem.4c02941

Chicago Style (17th ed.) Citation

Hazemann, Julien, Thierry Kimmerlin, Aengus Mac Sweeney, Geoffroy Bourquin, Roland Lange, Daniel Ritz, Sylvia Richard-Bildstein, Sylvain Regeon, and Paul Czodrowski. "Accelerating the Hit-To-Lead Optimization of a SARS-CoV-2 Mpro Inhibitor Series by Combining High-Throughput Medicinal Chemistry and Computational Simulations." Journal of Medicinal Chemistry 68, no. 8 (2025): 8269-8294. https://doi.org/10.1021/acs.jmedchem.4c02941.

MLA (9th ed.) Citation

Hazemann, Julien, et al. "Accelerating the Hit-To-Lead Optimization of a SARS-CoV-2 Mpro Inhibitor Series by Combining High-Throughput Medicinal Chemistry and Computational Simulations." Journal of Medicinal Chemistry, vol. 68, no. 8, 2025, pp. 8269-8294, https://doi.org/10.1021/acs.jmedchem.4c02941.